Skip to main content
SpringerLink
Log in

Peptide hormone analogues and novel clinical applications

  • Editors’ Column
  • Published:
Ricerca in clinica e in laboratorio

Summary

Clinical application of peptide hormone analogues is rapidly expanding. Pecullar aminoacid residues, conformational turns and the degree of molecular flexibility may represent critical keys for differential interaction with the receptor sites, hence for specific biological effects. Broadly different biological responses may be elicited as a function of dose and timing of administration. The clinical use of the heptadecapeptide analogue ACTH 1–17 (Synchrodyn® 1–17) has provided new diagnostic information about subtle alterations of the adrenal function and has been valuable to presetting the rhythmic ordering of several functions, especially of those which are more dependent on the glucocorticoid modulation. In this sense, the use of a synthetic hormone analogue presenting a wide range of programmable effects appears essential for a better medicine. A large body of evidence indicates that the same concept applies to most actions of the gonadotropin-releasing hormone (LH-RH) related analogues. The availability of small computerized instruments for data collection and analysis of the endogenous rhytmicities, on the one hand, and for programmable administration of the analogues, on the other hand, is already providing new approaches to heretofore unsuccessful therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Angeli A.: Circadian ACTH-rhythm in man. In:Aschoff J., Ceresa F., Halberg F. (Eds): Chronobiological aspects of endocrinology. Schattauer-Verlag, Stuttgart and New York, 1974; pp. 417–436.

    Google Scholar 

  2. Angeli A., Paccotti P., Orlandi F., Gaidano G., Ceresa F.: Differential patterns of plasma cortisol and aldosterone following stimulation with increasing doses of the synthetic analogue (β-Ala1, Lys17) ACTH-1–17-4-amino-N-burylamide—Hormone metab. Res.13, 24–27, 1981.

    CAS  Google Scholar 

  3. Barker J. L., Smith T. G.: The role of peptides in neuronal function. M. Dekker. New York, 1980; pp. 768.

    Google Scholar 

  4. Blundell T., Wood S.: The conformation, flexibility and dynamics of polypeptide hormones— Ann. Rev. Biochem.51, 123–154, 1982.

    Article  PubMed  CAS  Google Scholar 

  5. Bourne G. A., Regiani S., Payne A. H., Marshall J. C.: Testicular GnRH receptors: characterization and localization on interstitial tissue—J. clin. Endocrinol.51, 407–409, 1980.

    CAS  Google Scholar 

  6. Carandente F.: Sistemi biologici oscillanti—Fed. med. (Roma)36, 551–557, 1982.

    Google Scholar 

  7. Carandente F., De Matteis M. A., Melizzi R., Pitari G.: Circadian temporal structure evaluated by automatic monitoring—Chronobiologia9, 153–161, 1982.

    PubMed  CAS  Google Scholar 

  8. Ceresa F., Angeli A.: Chronothérapie corticoïde. In:Mirouze J. (Ed.): XIV Congrès International de Thérapeutique. L’Expansion Scientifique Française, Paris, 1977; pp. 211–223.

    Google Scholar 

  9. Chang K. J., Cuatrecasas P.: Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity—J. biol. Chem.254, 2610–2618, 1979.

    PubMed  CAS  Google Scholar 

  10. Conn P. M., Hazum E.: Luteinizing hormone releasing and gonadotropin-releasing hormone (GnRH) receptor internalization: independent actions of GnRH—Endocrinology110, 1108–1115, 1981.

    Google Scholar 

  11. De Wied D.: Behavioural effect of neuropeptides related to ACTH, MSH and βLPH—Ann. N.Y. Acad. Sci.297, 263–274, 1977.

    Article  PubMed  Google Scholar 

  12. Emson P.C.: Peptides as neurotransmitter candidates in the mammalian CNS—Progr. Neurobiol.13, 61–116, 1980.

    Article  Google Scholar 

  13. Fahrenkrug J., Gammeltoft S., Staunolsen P., Ottesen B., Sjöquist A.: Multiplicity of receptors for vasoactive intestinal polypeptide (VIP): differential effects of apamin on binding in brain, uterus and liver—Peptides4, 133–136, 1983.

    Article  PubMed  CAS  Google Scholar 

  14. Ferrari E., Bossolo P. A., Carnevale Schianca G. P., Solerte S. B., Fioravanti M., Nascimbene M.: Adrenocortical responsiveness to the synthetic ACTH-1–17 analogue given at different circadian stages—Chronobiologia9, 133–141, 1982.

    PubMed  CAS  Google Scholar 

  15. Geiger R.: Synthese eines Heptadecapeptids mithoher adrenccorticotroper Wirkung—Justus Liebigs Ann. Chem.750, 165–170, 1971.

    Article  CAS  Google Scholar 

  16. Geiger R.: Sintesi di ormoni peptidici. In: Istiruzioni di patologia del metabolismo (I). Etiologia e fisiopatologia. I Quaderni de “Il Ponte” no. 7, Milano. 1982; pp. 9–27.

  17. Gibson M. J., Krieger D. T.: Circadian corticosterone rhythm and stress response in rats with adrenal autotransplants—Amer. J. Physiol.240, E363-E366, 1981.

    PubMed  CAS  Google Scholar 

  18. Gispen W. H., Wiecant V. M., Greven H. M., De Wied D.: The induction of excessive grooming in the rat by intraventricular applications of peptides derived from ACTH: structure-activity studies—Life Sci.17, 645–653, 1975.

    Article  PubMed  CAS  Google Scholar 

  19. Greven H. M., De Wied D.: Structure and behavioural activity of peptides related to cortic-otrophin and lipotropin. In:De Wied D., van Keep P. A. (Eds): Hormones and the brain. MTP Press Ltd., Lancaster, England, 1980; pp. 115–127.

    Google Scholar 

  20. Halberg E., Halberg F.: Chronobiologic study design in everyday life, clinic and laboratory— Chronobiologia7, 95–120, 1980.

    PubMed  CAS  Google Scholar 

  21. Halberg F.: Some physiological and clinical aspects of 24-hour periodicity—J. Lancet (USA)73, 20–32, 1953.

    CAS  Google Scholar 

  22. Halberg F., Halberg E., Herold M., Vecsei P., Günther R., Reinberg A.: Toward a clinospectrometry of conventional and novel effects of ACTH 1–17—Synchrodyn®—in rodents and human beings. In:Takahashi R., Halberg F., Walker C. A. (Eds): Toward chronopharmacology. Proceedings of 8th IUPHAR Congress and satellite Symposia, Nagasaki, July 27–28, 1981. Pergamon Press, Oxford and New York, 1982; pp. 119–161.

    Google Scholar 

  23. Haus E., Halberg F., Sothern R. B., Lakatua D., Scheving L. E., Sanchez de la Peña S., Sanchez E., Melby J., Wilson Th., Brown H., Berg H., Levi F., Culley D., Halberg E., Hrushesky W., Pauly J.: Time-varying effects in mice and rats of several synthetic ACTH preparations—Chronobiologia7, 211–226, 1980.

    PubMed  CAS  Google Scholar 

  24. Hiroshige T., Sato T.: Postnatal development of circadian rhythm of corticotropin-releasing activity in the rat hypothalamas—Endocrinol. jap.17, 106–112, 1970.

    Google Scholar 

  25. Hsueh A. J. W., Jones P. B. C.: Extrapituitary actions of GnRH—Endocrinol. Rev.2, 437–461, 1981.

    CAS  Google Scholar 

  26. Krieger D. T.: Physiopathology of Cushing’s disease—Endocrinol. Rev.4, 22–43, 1983.

    CAS  Google Scholar 

  27. Krieger D. T., Allen W., Rizzo F.: Characterization of the normal pattern of plasma corticosteroid levels—J. clin. Endocrinol.32, 266–284, 1971.

    CAS  Google Scholar 

  28. Krieger D. T., Liotta A. S.: Pituitary hormones in brain: where, how and why?—Science205, 366–372, 1979.

    Article  PubMed  CAS  Google Scholar 

  29. Iversen L. L.: Nonopioid neuropeptides in mammalian CNS—Ann. Rev. Pharmacol. Toxicol.23, 1–27, 1983.

    Article  CAS  Google Scholar 

  30. Levi F., Halberg F., Haus E., Sanchez de la Peña S., Sothern R. B., Halberg E., Hrushesky W., Brown H., Scheving L. E., Kennedy B. J.: Synthetic adrenocorticotropin for optimizing murine circadian chronotolerance for adriamycin—Chronobiologia7, 227–244, 1980.

    PubMed  CAS  Google Scholar 

  31. Leyendecker G.: The pathophysiology of hypothalamic ovarian failure, Diagnostic and therapeutical considerations—Europ. J. Obstetr. Gynecol. reprod. Biol.9, 175–186, 1979.

    CAS  Google Scholar 

  32. Lindner E., Schölkens B.: ACTH and α-MSH: cardiovascular and antiarrhythmic properties— Arch. int. Pharmacodyn.208, 19–23, 1974.

    PubMed  CAS  Google Scholar 

  33. Low M., Kisfaduly L., Farmadjian S.: Proposed conformation of ACTH—Acta biochim. biophys. Acad. Sci. hung.10, 229–238, 1975.

    PubMed  CAS  Google Scholar 

  34. Marshall J. C., Kelch R. P.: Low dose pulsatile gonadotropin releasing hormone inanorexia nervosa: a model of human pubertal development—J. clin. Endocrinol.49, 712–718, 1979.

    CAS  Google Scholar 

  35. Moldow R. L., Fischman A. J.: Physiological changes in rat hypothalamic CRF: circadian, stress and steroid suppression—Peptides3, 837–840, 1982.

    Article  PubMed  CAS  Google Scholar 

  36. Momany F. A.: Conformational energy analysis of the molecule luteinizing hormone releasing hormone. 1. Native decapeptide—J. Amer. chem. Soc.98, 2990–2997, 1976.

    Article  CAS  Google Scholar 

  37. Mullen P.: Sleep and its interaction with endocrine rhythms—Brit. J. Psychiatr.142, 215–220, 1983.

    CAS  Google Scholar 

  38. Mullen P., Jeffcoate W. J., Linsett C., Howard R., Rees L. H.: The circadian variation of immunoreactive lipotrophin and its relationship to ACTH and growth hormone in man— Clin. Endocrinol.11, 533–539, 1979.

    Article  CAS  Google Scholar 

  39. Nillius S. J.: The therapeutic uses of gonadotrophin-releasing hormones and its analogues. In:Beardwell C., Robertson G. L. (Eds): The pituitary. Butterworths, London, 1982; pp. 211–227.

    Google Scholar 

  40. Partridge W. M.: Neuropeptides and the blood brain barrier—Ann. Rev. Physiol.45, 73–82, 1983.

    Article  Google Scholar 

  41. Partridge W. M., Meitus L. J.: Enkephalin and the blood-brain barrier: studies of binding and degradation in isolated brain microvessels—Endocrinology109, 1138–1143, 1981.

    Google Scholar 

  42. Reeves J. J., Seguin C., Lefebvre F. A., Kelly P. A., Labrie F.: Similar LHRH binding sites in rat anterior pituitary and ovary—Proc. nat. Acad. Sci. (Wash.)77, 5567–5571, 1980.

    Article  CAS  Google Scholar 

  43. Reinberg A., Brière L., Fraboulet G., Guillemant S., Touitou Y., Lagoguey M., Guillemant J., Dupont W., Guillet Ph., Nicolai A.: Clinical chronopharmacology of ACTH 1–17. III. Effects on fatigue, oral temperature, heart rate, grip strength and bronchial patency— Chronobiologia8, 101–115, 1981.

    PubMed  CAS  Google Scholar 

  44. Reinberg A., Dupont W., Touitou Y., Lagoguey M., Bourgeois Ph., Touitou C., Muriaux G., Przyrowsky D., Guillemant S., Guillemant J., Brière L., Zeau B.: Clinical chronopharmacology of ACTH 1–17. II. Effects on plasma testosterone, plasma aldosterone, plasma and urinary electrolytes (K, Na, Ca and Mg)—Chronobiologia8, 11–31, 1981.

    PubMed  CAS  Google Scholar 

  45. Resko J. A., Belanger A., Labrie F.: Effects of chronic treatment with a potent luteinizing-hormone-releasing hormone agonist on serum luteinizing hormone and steroid levels in the malerhesus monkey—Biol. Reprod.26, 378–384, 1982.

    Article  PubMed  CAS  Google Scholar 

  46. Sanchez de la Peña S., Halberg F., Ungar F.: Pineal chronomodulation—the feed-sideward —Clin. Chem. Newsletter2, 129–133, 1982.

    Google Scholar 

  47. Sanchez de la Peña S., Halberg F., Ungar F., Haus E., Lakatua D., Scheving L. E., Sanchez E., Vecsei P.: Circadian pineal modulation of pituitary effect on murine corticosteronein vitro—Brain Res. Bull.10, 559–565, 1983.

    Article  PubMed  Google Scholar 

  48. Sandow J.: The regulation of LHRH action at the pituitary and gonadal receptor level: a review—Psychoneuroendocrinology8, 277–297, 1983.

    Article  PubMed  CAS  Google Scholar 

  49. Sandow J., Geiger R., Vogel H. G.: Pharmacological effects of a short chain ACTH analogue— Naunyn-Schmiederberg’s Arch. exp. Pathol. Pharmakol.297 (Suppl. 2), R 41, 1977. (Abstract).

    Google Scholar 

  50. Schwyzer R.: ACTH: a short introductory review—Ann. N.Y. Acad. Sci.297, 2–26, 1977.

    Article  Google Scholar 

  51. Schwyzer R.: Peptides and the new endocrinology—Naturwissenschaften69, 15–20, 1982.

    Article  PubMed  CAS  Google Scholar 

  52. Skarin G., Nillius S. J., Wibell L., Wide L.: Caronic pulsatile low dose GnRH therapy for induction of testosterone production and spermatogenesis in a man with secondary hypogonadotropic hypogonadism—J. clin. Endocrinol.55, 723–726, 1982.

    CAS  Google Scholar 

  53. Swerdloff R. S., Heber D.: Superactive gonadotropin-releasing hormone agonists—Ann. Rev. Med.34, 491–500, 1983.

    Article  PubMed  CAS  Google Scholar 

  54. Tilders F. J. H., Smelik P. G.: A diurnal rhythm in melanocyte-stimulating hormone content of the rat pituitary gland and its independence from the pineal gland—Neuroendocrinology17, 296–302, 1975.

    Article  PubMed  CAS  Google Scholar 

  55. Tolis G., Mehta A., Chapdelaine A.: Application of LHRH and its superactive analogues in reproductive biology—Front. Hormone Res.10, 43–64, 1982.

    CAS  Google Scholar 

  56. Vale W., Spiess J., Rivier C., Rivier J.: Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin—Science213, 1394–1397, 1981.

    Article  PubMed  CAS  Google Scholar 

  57. Van Ree J. M., De Wied D.: Central nervous system effects of pro-opiomelanocortin peptides— Acta endocrinol. (Kbh.)103 (Suppl. 256), 23, 1983, (Abstract).

    Google Scholar 

  58. Vierhapper H., Waldhäusl W.: Comparison of the corticotropic action of two synthetic, substituted analogues of ACTH: ACTH 1–17 and ACTH 1–18—J. clin. Endocrinol.47, 208–211, 1978.

    CAS  Google Scholar 

  59. Weitzman E. D.: Circadian rhythms and episodic hormone secretion in man—Ann. Rev. Med.27, 225–243, 1976.

    Article  PubMed  CAS  Google Scholar 

  60. Wilson J. F., Morgan M. A.: Cyclical changes in concentrations of α-melanotropin in the plasma of male and female rats—J. Endocrinol.82, 361–365, 1979.

    Article  PubMed  CAS  Google Scholar 

  61. Zeiler R. H., Strand F., El-Sharif N.: Electrophysiological and contractile responses of canine atrial tissue to adrenocorticotropin—Peptides3, 815–822, 1982.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Medicina Interna, Cattedra di Patologia Speciale Medica e Metodologia Clinica D, Università di Torino, Torino, Italy

    Alberto Angeli

Authors
  1. Alberto Angeli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Angeli, A. Peptide hormone analogues and novel clinical applications. La Ricerca Clin. Lab. 14, 123–135 (1984). https://doi.org/10.1007/BF02904965

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02904965

Key-words

Search

Navigation